Opioid Crisis Compensation: Billions for Victims or Empty Promises?
Tammy Blanton's experience highlights challenges in obtaining compensation from Purdue Pharma's bankruptcy settlement, which requires proving use of Purdue-manufactured opioids. Many face documentation obstacles, with records often destroyed or unobtainable, leaving victims struggling for compensation amid complex legal processes and constraining settlement terms.
Amid Purdue Pharma's bankruptcy settlement, victims like Tammy Blanton face significant hurdles in proving their eligibility for compensation. Her mother's tragic case underscores the difficulty in meeting documentation requirements, as many struggle to provide the necessary records due to time lapse and other constraints.
The bankruptcy plan stipulates claimants must prove they received Purdue-manufactured opioids—which can be near impossible years later when records have been destroyed. As victims fight for compensation, the settlement's documentation demands have become a major roadblock, leaving many without recourse.
Despite the billions set aside, the settlement process remains mired in bureaucracy. As thousands of claims are rejected, the hopes of those affected by the opioid crisis hang by a thread, raising questions about the justice and efficacy of current compensation mechanisms.
(With inputs from agencies.)
Google News